Breaking News

Esoterix, DHMRI In Assay Services Pact

Adds discovery capabilities to biomarker tools of LabCorp unit

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Esoterix Clinical Trials Services, a division of LabCorp, entered a strategic alliance with the David H. Murdock Research Institute (DHMRI) to provide its clients with access to assay development services. Assays developed at DHMRI will be transferred to LabCorp Clinical Trials labs worldwide to support global clinical studies. The agreement also provides a mechanism for downstream commercialization of companion diagnostics and other biomarker assays once clinical validation has been established...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters